IP Library Granted Patent US 10,342,699
Granted Patent B2
US 10,342,699 · App. 16/228,316 · Granted Jul 9, 2019

Systems and methods for treating eye diseases

Inventors: Michael Calhoun (Lighthouse Point, FL); Jeff Franco (Plano, TX); Robert M. Vidlund (Forest Lake, MN)
Assignee: J.D. FRANCO & CO., LLC
A61F9/007A61F2/856A61F2/966A61F9/00781A61M25/104A61M27/00A61B17/12109A61B17/12136A61F2002/821A61M2025/1052
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,342,699
App. No.
16/228,316
Granted
Jul 9, 2019
Kind
B2
Abstract

A method may include accessing a terminal branch of an ophthalmic artery through a face of a subject via first device. Additionally, the method may include positioning the first device or a second device within the ophthalmic artery of the subject and treating a blockage, a stenosis, a lesion, plaque or other physiology in the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

Claims (33)

1. A method, comprising:

accessing a terminal branch of an ophthalmic artery through a face of a subject via a first device;

positioning the first device or a second device within the ophthalmic artery of the subject; and

treating a blockage, a stenosis, a lesion, plaque, or other physiology in the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

2. The method of claim 1 , further including inducing retrograde blood flow in the ophthalmic artery.

3. The method of claim 1 , wherein the treating includes increasing a blood flow rate in the ophthalmic artery.

4. The method of claim 1 , wherein the treating includes increasing a size of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery.

5. The method of claim 4 , wherein the increasing the size of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes removing material.

6. The method of claim 4 , wherein the increasing the size of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes using a balloon in a balloon dilation procedure.

7. The method of claim 1 , further including measuring a blood flow rate in the ophthalmic artery.

8. The method of claim 7 , wherein the measuring the blood flow rate in the ophthalmic artery includes at least one of measuring a linear blood flow rate or a volumetric blood flow rate.

9. The method of claim 1 , further including stopping antegrade blood flow in the ophthalmic artery.

10. The method of claim 1 , wherein accessing the terminal branch of the ophthalmic artery through the face of the subject includes accessing the ophthalmic artery through a facial skin of the subject via the first device.

11. The method of claim 1 , wherein the accessing the terminal branch of the ophthalmic artery through the face of the subject includes accessing a supraorbital or supratrochlear artery of the subject via the first device.

12. A method, comprising:

positioning a first device in a terminal branch of an ophthalmic artery through a face of a subject;

stopping antegrade flow in the ophthalmic artery; and

treating a blockage, a stenosis, a lesion, plaque, or other physiology in the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

13. The method of claim 12 , further including inducing retrograde blood flow in the ophthalmic artery.

14. The method of claim 12 , wherein the positioning the first device in the terminal branch of the ophthalmic artery through the face of the subject includes positioning the first device in at least one of a supraorbital artery or a supratrochlear artery.

15. The method of claim 12 , wherein the treating includes increasing a blood flow rate in the ophthalmic artery.

16. The method of claim 15 , wherein the treating includes increasing a size of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery.

17. The method as in claim 16 , wherein the increasing the size of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes removing material.

18. The method as in claim 16 , wherein the increasing the size of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes using a balloon.

19. The method of claim 12 , further including measuring a blood flow rate in the ophthalmic artery.

20. The method as in claim 19 , wherein the measuring the blood flow rate in the ophthalmic artery includes measuring at least one of a linear blood flow rate or a volumetric blood flow rate.

21. A method, comprising:

locating a site in an arterial blood supply to an eye that compromises blood flow and contributes to an eye disorder;

accessing a terminal branch of an ophthalmic artery through a face of a subject via a first device;

delivering the first device or a second device intravascularly to the site; and

treating the site with the first device or the second device.

22. The method of claim 21 , wherein the site is located in the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

23. The method of claim 21 , further including stopping antegrade blood flow in the ophthalmic artery or inducing retrograde blood flow in the ophthalmic artery.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: VIDLUND, ROBERT
To: OCUDYNE, INC.
Reel/Frame 048594/0728 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: CALHOUN, MICHAEL
To: OCUDYNE, INC.
Reel/Frame 048594/0742 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2019
From: FRANCO, JEFF
To: OCUDYNE, INC.
Reel/Frame 048594/0752 →
Continuity (14)
Continuation In Part 15971809 · May 4, 2018
Continuation 15681075 · Aug 18, 2017
Continuation 16228316
Continuation In Part PCTUS2017051551 · Sep 14, 2017
Continuation PCTUS2017021673 · Mar 9, 2017
Continuation 16228316
Continuation In Part 15609547 · May 31, 2017
Continuation 14385496
Provisional Application 62396091 · Sep 16, 2016
Provisional Application 62395294 · Sep 15, 2016
Provisional Application 62314340 · Mar 28, 2016
Provisional Application 62305991 · Mar 9, 2016
Provisional Application 61679351 · Aug 3, 2012
Related Publication 20190142631A1 · May 16, 2019
Cited By (1)
US 12,318,327